9
4
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP1045L |
Orexin B, rat, mouse Acetate
Rat orexin B,Orexin B (mouse) Acetate,Orexin B, rat, mouse Acetate(202801-92-1 free base) |
OX Receptor | GPCR/G Protein; Neuroscience |
Orexin B, rat, mouse Acetate (Rat orexin B)(202801-92-1 free base) 是 Orexin 受体的内源性激动剂,对 OX1 和 OX2 的 Kis 分别为 420 和 36 nM。 | |||
TP1975L |
[Ala11,D-Leu15]-Orexin B acetate
[Ala11,D-Leu15]-Orexin B acetate (532932-99-3 Free base) |
OX Receptor | GPCR/G Protein; Neuroscience |
[Ala11,D-Leu15]-Orexin B acetate 是一种特异性 orexin-2 受体 (OX2) 激动剂,EC50 为 0.13 nM,比 OX1 (52 nM) 特异性高 400 倍。 | |||
TP1139 |
Orexin B, human
Human orexin B |
||
Orexin B, human is an endogenous agonist at Orexin receptor with Kis of 420 and 36 nM for OX1 and OX2, respectively. Orexin B is a hypothalamatic neuropeptide stimulating food intake in rats. | |||
TP1045 |
Orexin B, rat, mouse
Orexin B (mouse),Rat orexin B |
||
Orexin B, rat, mouse is an endogenous agonist at Orexin receptor with Kis of 420 and 36 nM for OX1 and OX2, respectively. | |||
TP1975 |
[Ala11,D-Leu15]-Orexin B(human)
[Ala11,D-Leu15]-Orexin B |
||
Highly potent and selective OX2 receptor agonist; displays 400-fold selectivity over OX1 receptors. EC50 values are 0.13 and 52 nM for human OX2 and OX1 receptors respectively. | |||
TP1138 |
Orexin B, human TFA (205640-91-1 free base)
Orexin B, human TFA,Human orexin B TFA |
||
Orexin B, human (TFA) is an endogenous agonist at Orexin receptor with Kis of 420 and 36 nM for OX1 and OX2. | |||
T75920 |
Orexin B, human TFA
|
||
Orexin B, human (TFA) 是 Orexin 受体的内源性激动剂,与 OX1和 OX2结合的 Ki 值分别为 420 和 36 nM。 | |||
T75925 |
Orexin B, rat, mouse TFA
|
||
Orexin B, rat, mouse (Rat orexin B) TFA,作为一种内源性促进食欲的(Orexin receptor)激动剂,通过结合并激活两个亲密相关的孤儿G蛋白偶联受体OX1-R和OX2-R,促进食物摄入和能量消耗,并在睡眠-觉醒调节中扮演关键角色。 | |||
T75921 |
[Ala11,D-Leu15]-Orexin B(human) TFA
|
||
[Ala11,D-Leu15]-Orexin B(human) TFA为高效的orexin-2 receptor (OX2)选择性激动剂。其对OX2展现出比OX1 (52 nM) 高达400倍的较高选择性(EC50=0.13 nM)。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-01816 |
OX1R Protein, Human, Recombinant (His & SUMOstar)
Hypocretin receptor type 1,Orexin receptor type 1,<... |
Human | P. pastoris (Yeast) |
Moderately selective excitatory receptor for orexin-A and, with a lower affinity, for orexin-B neuropeptide. Triggers an increase in cytoplasmic Ca(2+) levels in response to orexin-A binding. OX1R Protein, Human, Recombinant (His & SUMOstar) is expressed in yeast with N-6xHis-sumostar tag. The predicted molecular weight is 21.4 kDa and the accession number is O43613. | |||
TMPK-01413 |
H-2K (b) &B2M&OVA (SIINFEKL) Monomer Protein, Mouse, MHC (His & Avi)
H-2K,OVA,MHC,H2-K1 |
Mouse | HEK293 Cells |
Ovalbumin (OVA) has been historically a popular source of such antigens, since OVA can induce both humoral and cellular immune responses based on well-characterised peptide epitopes. The OVA257-264 octapeptide was one of the frst OVA epitopes to be characterised, it has an amino acid sequence SIINFEKL, which is recognised by cytotoxic T lymphocytes. SIINFEKL forms fbrillar assemblies similar to other peptide hydrogels. Te immunoactive properties of this peptide can therefore be related to its se... | |||
TMPK-01412 |
HLA-B*15:01&B2M&SARS-CoV-2 epitope (NQKLIANQF) Monomer Protein, Human, MHC (His & Avi)
SARS-CoV-2 epitope,MHC |
Human | HEK293 Cells |
HLA-B*15:01 is strongly associated with asymptomatic infection with SARS-CoV-2 and is likely to be involved in the mechanism underlying early viral clearance. T cells from pre-pandemic individuals carrying HLA-B*15:01 were reactive to the immunodominant SARS-CoV-2 S-derived peptide NQKLIANQF, and 100% of the reactive cells displayed memory phenotype. | |||
TMPK-01416 |
HLA-B*15:01&B2M&SARS-CoV-2 epitope (NQKLIANQF) Monomer Protein, Human, MHC (His & Avi), Biotinylated
MHC,SARS-CoV-2 epitope |
Human | HEK293 Cells |
HLA-B*15:01 is strongly associated with asymptomatic infection with SARS-CoV-2 and is likely to be involved in the mechanism underlying early viral clearance. T cells from pre-pandemic individuals carrying HLA-B*15:01 were reactive to the immunodominant SARS-CoV-2 S-derived peptide NQKLIANQF, and 100% of the reactive cells displayed memory phenotype. |